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Background: Maternal mortality has declined by nearly half since 1990, but over a quarter million women still die
every year of causes related to pregnancy and childbirth. Maternal-health related targets are falling short of the
2015 Millennium Development Goals and a post-2015 Development Agenda is emerging. In connection with this,
setting global research priorities for the next decade is now required.
Methods: We adapted the methods of the Child Health and Nutrition Research Initiative (CHNRI) to identify and set
global research priorities for maternal and perinatal health for the period 2015 to 2025. Priority research questions
were received from various international stakeholders constituting a large reference group, and consolidated into a
final list of research questions by a technical working group. Questions on this list were then scored by the
reference working group according to five independent and equally weighted criteria. Normalized research priority
scores (NRPS) were calculated, and research priority questions were ranked accordingly.
Results: A list of 190 priority research questions for improving maternal and perinatal health was scored by 140
stakeholders. Most priority research questions (89%) were concerned with the evaluation of implementation and
delivery of existing interventions, with research subthemes frequently concerned with training and/or awareness
interventions (11%), and access to interventions and/or services (14%). Twenty-one questions (11%) involved the
discovery of new interventions or technologies.
(Continued on next page)* Correspondence: jpsouza@fmrp.usp.br
1UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research,
Development and Research Training in Human Reproduction (HRP),
Department of Reproductive Health and Research, World Health
Organization, Geneva, Switzerland
2Department of Social Medicine, Ribeirão Preto Medical School, University of
São Paulo, Ribeirão Preto, São Paulo, Brazil
Full list of author information is available at the end of the article
© 2014 Souza et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Souza et al. Reproductive Health 2014, 11:61 Page 2 of 9
http://www.reproductive-health-journal.com/content/11/1/61(Continued from previous page)
Conclusions: Key research priorities in maternal and perinatal health were identified. The resulting ranked list of
research questions provides a valuable resource for health research investors, researchers and other stakeholders.
We are hopeful that this exercise will inform the post-2015 Development Agenda and assist donors, research-policy
decision makers and researchers to invest in research that will ultimately make the most significant difference in the
lives of mothers and babies.
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In 2000, heads of States and Governments gathered at the
United Nations General Assembly and agreed to put in
place an international effort to eradicate extreme poverty
and promote human development. The 2000 Millennium
Summit resulted in a series of time-bound targets (the
Millennium Development Goals - MDGs) which include
improving maternal health and reducing child mortality
by 2015. Improving maternal health, considered a crucial
element to combat poverty and underdevelopment on a
global scale, consisted of two components: reducing ma-
ternal mortality, and achieving universal access to repro-
ductive health services [1].
Maternal mortality has declined by nearly half since
1990, but this progress falls short of the MDG target
and over a quarter million women still die every year of
causes related to pregnancy and childbirth [2,3]. Mater-
nal health-related indicators are among the worst per-
forming in the MDG effort; and only a small number of
countries will reach their maternal mortality targets by
2015 [3]. Despite this relatively slow progress, it is widely
believed that the interventions needed to reduce mater-
nal mortality ratios (MMR) to less than 50 deaths per
100,000 live births per year globally, already exist [4].
Obstacles to implementing effective interventions and
disseminating knowledge delay progress, particularly in
the least developed countries and most vulnerable popu-
lations. With the deadline for the MDGs approaching,
the international community is currently mobilizing to
develop plans for the post-MDG era [4]. As a part of this
global effort, we conducted an international survey and
prioritization exercise to identify key research priorities
that could accelerate improvement in maternal and peri-
natal health from 2015 to 2025.
The Child Health and Nutrition Research Initiative
(CHNRI) has developed a method to assist policy makers,
donors and stakeholders in understanding the potential of
different research avenues to contribute to reducing the
burden of disease and disability [5]. This method is par-
ticipatory, identifies weaknesses and strengths of proposed
research options and enables transparent prioritization for
research investment [5-7]. The CHNRI methods have
been adapted and applied at national and internationallevels in various fields and the World Health Organization
(WHO) has used these methods for several previous
research prioritization exercises [8-11]. In this paper, we
present the results of the WHO research prioritization
exercise using adapted CHNRI methods to identify global
research priorities for maternal and perinatal health.
Methods
The CHNRI methods have been previously published to-
gether with detailed guidelines for implementation [5].
The goal of our priority setting exercise was to identify
research questions with the potential to have an impact
on maternal and perinatal health indicators between
2015 and 2025. In this context, maternal health’ relates
to conditions affecting women during pregnancy, child-
birth/abortion and up to six weeks postpartum/post-
abortion, and ‘perinatal health’ relates to conditions
affecting offspring from the time of fetal viability to the
first 28 postnatal days. This process was managed by the
WHO and implemented in three phases: (1) the gener-
ation and collection of research questions, (2) thematic
analysis and consolidation of research questions, and (3)
prioritization of research questions using a scoring sys-
tem based on five criteria. Figure 1 illustrates this
process.
Phase I was initiated by establishing a reference group
of researchers, health care providers, program man-
agers, and other stakeholders (including representatives
of consumer groups and donors). An invitation was sent
to a large number of active researchers in the field of
maternal and perinatal health, identified through bib-
liographic metrics and other information available in
the “BiomedExperts” database. This database includes
over 400,000 registered members and 1.8 million pre-
generated profiles of life science researchers (http://
www.biomedexperts.com/). Potential participants were
identified in the BiomedExperts database using a pre-
specified search strategy available in Appendix 1. The
identification of researchers was stratified to ensure
participation of researchers from both developed and
developing countries. In addition, invitations were also
sent to program managers and policymakers identified
in contact lists of WHO and partner organizations (e.g.
Figure 1 Study and analysis flow.
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(USAID) Maternal and Child Health Integrated Pro-
gram (MCHIP)). Those who responded positively to
the invitation became members of the reference group.
All members of the reference group were invited to pro-
vide three research questions in seven domains: obstet-
ric haemorrhage, hypertensive disorders of pregnancy
(HDP), maternal sepsis, abortion, difficult/obstructed
labour, preterm birth, and stillbirth. Maternal and peri-
natal health research questions identified through other
processes (including a USAID priority setting exercise,
published WHO guidelines, and a previous WHO
CHNRI intrapartum priority setting exercise) were also
included in the index list of research questions [12-16].
In Phase II, this long list of questions was independ-
ently assessed by two researchers (MW and SJP) for
identification of duplicate questions. Questions that were
out of scope (i.e. not pertaining to any of the previously
mentioned domains), or that were too broad to be con-
sidered research questions (e.g. “research to reduce ma-
ternal mortality”, “develop and test interventions for
reducing postpartum haemorrhage”), or that were con-
sidered epidemiological (non-intervention) research,
were excluded. This process was reviewed by a thirdresearcher (JPS), who resolved discrepancies. A reduced
list of questions was then submitted to thematic analysis.
The thematic analysis consisted of grouping similar
questions together to identify research themes and sub-
themes. This allowed us to identify additional duplicates
and out-of-scope questions. Questions were edited for
clarity and similar questions were merged. During this
process, we aimed to achieve a certain level of detail
compatible with the concept of “research avenues” (i.e. a
research question that is not too broad, neither too spe-
cific, and could be answered through a set of individual
research projects); hence, very detailed and specific
questions were made more general. This process re-
sulted in a refined list of questions for the technical con-
sultation meeting held in Geneva in April 2013. The
large majority of the participants in this technical con-
sultation was selected from amongst the reference group
and composed the technical working group. This tech-
nical working group consisted of a diverse group of 22
participants that included clinical specialists, researchers,
program managers, WHO officers, donor and consumer
representatives, and other stakeholders. During this
technical consultation, the product of the thematic ana-
lysis was reviewed, new questions were developed where
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were further consolidated.
Phase III consisted of scoring the final list of research
questions. To reduce bias due to participant fatigue, we
prepared six spreadsheets that differed in the order in
which the research questions were presented. Each mem-
ber of the reference group received one of these electronic
spreadsheets via e-mail, accompanied by a score sheet
consisting of five criteria to be used for scoring the ques-
tions. These five criteria included answerability, effective-
ness, deliverability, maximum potential for disease burden
reduction, and equity (Table 1). They are described in de-
tail in the CHNRI guidelines [5]. The participants were
instructed to score the questions one criterion at a time
using a binary score system (1: Yes, 0: No). If they were
not sure, did not know, or were not able to make a judg-
ment, they were asked to leave the question blank. The
completed spreadsheets, when returned by the partici-
pants, were integrated into a database.
A research priority score was generated for each ques-
tion by summing up the scores attributed to each criter-
ion. No special weighting of criteria was applied. Thus,
for each individual respondent, each research question
could have a priority score ranging from 0 to 5. The
overall research priority score was computed as the sum
of all individual research priority scores. For each ques-
tion, the overall research priority score was normalized
(i.e. considering all questions, the overall research prior-
ity score for the question was subtracted by the mini-
mum research priority score among all questions, and
divided by the range: (x −min)/(max −min)). The nor-
malized research priority score (NRPS) was analyzed and
the cut-off point, enabling identification of the upper
quartile (questions with the highest normalized research
priority scores), was determined. Online Google® forms
were used to capture online data from the reference
group and Microsoft Excel (2010) spreadsheets were
used to score and analyze the responses provided.
Results
A total of 650 stakeholders responded positively to our
initial invitation to participate in this exercise and wereTable 1 Scoring criteria for setting research priorities
1. Answerability The research question can be ethically answered.
2. Effectiveness The new knowledge is likely to result in an effective
intervention or program.
3. Deliverability The intervention or program will be deliverable,
acceptable and affordable.
4. Potential
impact
The intervention or program has the potential to
substantially reduce maternal and perinatal
mortality, morbidity and long term disabilities.
5. Equity The intervention or program will reach the most
vulnerable groups.included in the reference group. Of these, 339 participants
(52%) provided 980 research ideas or questions; these were
considered together with 95 research questions generated
through other recent research prioritization processes. Par-
ticipants from 67 countries provided research ideas or
questions (22 developed countries contributed with 44% of
participants, 45 developing countries contributed with 56%
of participants). Researchers (37%; 125/339), Clinician phy-
sicians (27%; 92/339); program managers and policy makers
(20%; 67/339) were the main providers of research ques-
tions. Midwives, donor representatives, consumers and
other stakeholders provided also research questions. After
exclusion of duplicates, thematic analysis and editing, 234
questions were discussed by the technical working group,
working closely with the WHO management team, at the
technical consultation meeting held in Geneva. The tech-
nical consultation produced a consolidated list with 190
research questions, which was sent to the reference group
for scoring. A total of 140 participants (22%) of the refer-
ence group scored the questions and returned completed
spreadsheets, which were integrated into one database.
The distribution of research questions generated per
theme is shown in Figure 2. Overall, most of the research
questions (89%) address the implementation of existing
interventions or knowledge (delivery/implementation re-
search); 21 questions (11%) address research to discover
new interventions or technologies (discovery research).
Additional file 1 contains the database with all re-
search priority questions and criteria scores. Normalized
scores for the 190 questions ranged from 0 to 100.
Questions with a NRPS of 76 and above formed part of
the upper quartile of highest ranked questions (56 in
total). These were fairly evenly distributed, with each of
the main themes attracting six to nine questions in the
upper quartile (Table 2).
The top 20 highest ranked questions overall are pre-
sented in Table 3. Abortion research makes up 25% (n = 5)
of the top 20 list with other major themes including health
systems research (n = 4), obstetric haemorrhage (n = 3),
neonatal care (n = 3), and labour/delivery (n = 2). Training
and/or awareness interventions comprise 30% (n = 6) of
the sub-themes of these top 20 research priorities.
Hypertensive disorders of pregnancy (HDP) is not rep-
resented in the top-20 list but comprises 14% of the
questions in the upper quartile. Similarly, none of the
upper quartile questions were ‘discovery’ questions. The
five highest scoring discovery questions with their rank-
ing can be found in Table 4.
Discussion
The current exercise led to the identification of research
questions that are mostly related to implementation of
existing interventions and the development of simplified,
more cost-effective versions of existing interventions
Figure 2 Priority research questions (N = 190) by theme.
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treatment or magnesium sulfate for eclampsia). A lim-
ited number of questions related to the discovery of new
solutions were proposed (e.g. new uterotonics for PPH
or new ways to identify PPH). The opinions expressed
by the participants through their input in this process
appear to corroborate the notion that the biggestTable 2 Breakdown of research question flow by themes
Research themes and common sub-themes
Labour and delivery: Preterm birth, difficult/obstructed labour, fetal
monitoring, the partograph, training and/or awareness, caesarean section,
management of the third stage, induction of labour
Obstetric haemorrhage: Misoprostol access, uterotonics (type, dose, route),
screening and detection, training and/or awareness, care quality, blood
transfusions, management of the third stage
Hypertensive disorders of pregnancy: Screening and detection, magnesiu
sulphate, biochemical markers, anticonvulsants, antihypertensive agents,
training and/or awareness, prevention
Abortion: Post-abortion contraception, misoprostol access, post-abortion
follow-up, abortion in restricted settings, second trimester abortion, training
and/or awareness
Antenatal care: Screening and detection (including impaired fetal growth,
infection, preterm birth, anaemia), ultrasound access, nutrition, malaria, diabe
care
Health systems: Transport and communication, service quality, emergency
services, mobile community health services, supervision and mentoring, servi
utilization, monitoring and audits
Neonatal care: Neonatal resuscitation, hypoxic ischaemic encephalopathy,
screening and detection, kangaroo mother care, cord care, care of preterm
neonates, training and/or awareness
Other: Puerperal sepsis, postnatal care, improving attitudes/behaviour of
healthcare workers
*Upper quartile questions with a normalized research priority score (NRPS) of 76 anchallenge in current maternal and perinatal health is to
increase the outreach of existing effective solutions for
those who need them most.
These results represent the consensus view of a large
number of researchers, policymakers and other stake-
holders internationally, and provide the essential routes to
action to eliminate preventable maternal deaths by 2025.Total questions
(N = 190)
Top-ranked questions*
(n = 56)
Top-twenty questions
(n = 20)
39 (21%) 6 (11%) 2 (10%)
28 (15%) 8 (14%) 3 (15%)
m 21 (11%) 8 (14%) 0 (0%)
20 (11%) 8 (14%) 5 (25%)
tes
21 (11%) 6 (11%) 2 (10%)
ce
19 (10%) 8 (14%) 4 (20%)
26 (14%) 9 (16%) 3 (15%)
16 (8%) 2 (4%) 1 (5%)
d above.
Table 3 Top 20 (highest scoring) research priority questions to improve maternal and/or perinatal health outcomes
between 2015 and 2025
Research question NRPS Theme
Evaluate the effectiveness of interventions (e.g. counselling or incentives, or home visits) to increase post-abortion
contraception uptake and continuance, and reduce repeat abortion
100 Abortion
Evaluate the effectiveness and costs of strategies to improve the quality and utilization of maternity services (e.g.
maternity waiting homes, improved communication via mobile phones, community awareness strategies) to improve
early detection and management of antenatal and intrapartum complications
95 Health systems
Develop and evaluate strategies for locally appropriate transport, communication and referral systems for obstetric and
newborn emergencies
94 Health systems
Evaluate the effectiveness and cost of strategies to prevent, detect and treat causes of anaemia in pregnancy (e.g.
malaria, occult bleeding disorders, nutritional deficiencies)
93 Antenatal care
Evaluate the effectiveness and cost of training interventions for frontline healthcare workers (paramedics, doctors, CHWs,
midwives, nurses) to diagnose, manage and refer women with obstetric haemorrhage
92 Obstetric
haemorrhage
Evaluate the effectiveness and cost of a package of community level interventions for preterm babies (e.g. implementing
and providing guidelines for kangaroo mother care, home visits by CHWs, infection prevention strategies)
92 Neonatal care
Evaluate the effectiveness of integrating abortion services into existing family planning services 91 Abortion
Evaluate the effectiveness and cost of training frontline healthcare workers, including nurses, midwives and community
health workers, to detect and treat neonatal sepsis (or to provide pre-referral treatment only)
90 Neonatal care
Develop and evaluate community-based awareness programs to reduce unwanted pregnancies and encourage women
to seek help early
89 Abortion
Evaluate the effectiveness and cost of training interventions for skilled birth attendants to gain and maintain
competence in the management of obstructed labour, and assisted delivery techniques
88 Labour and
delivery
Evaluate the effectiveness and cost of training skilled birth attendants in intrapartum fetal monitoring and neonatal
resuscitation for reducing stillbirths and deaths/disability due to perinatal asphyxia
88 Neonatal care
Evaluate the effectiveness and cost of a package of interventions for the prevention, early detection and treatment of
puerperal sepsis (e.g. sterile birth kits, access to antibiotics, automated thermometers)
88 Other (puerperal
sepsis)
Evaluate the effectiveness and cost of a package of mobile service interventions delivered at community level, including
mobile clinics and home-based care, on maternal and perinatal health outcomes
87 Health systems
Evaluate the effectiveness, safety and timing of the initiation of post-abortion contraception (hormonal and IUDs) with
respect to abortion outcomes, contraceptive effectiveness, uptake, continuance, and repeat abortions
87 Abortion
Develop and evaluate the effectiveness and cost of strategies to improve access of women with obstetric haemorrhage
to blood and blood replacement products in settings without transport capabilities
87 Obstetric
haemorrhage
Develop and evaluate the effectiveness of strategies to increase access of women to misoprostol at community level
where oxytocin is not available/feasible, by dispensing it antenatally as part of a birthing kit, or at the time of delivery via
the attending CHW or nurse/midwife, to prevent and treat PPH
87 Obstetric
haemorrhage
Develop and evaluate strategies to increase appropriate use of the partograph, including decision-making and action, to
improve maternal and perinatal health outcomes
85 Labour and
delivery
Evaluate the effectiveness and cost of strategies, including task-shifting, to increase access of women to high quality
post-abortion care to improve early detection of complications
85 Abortion
Assess the effectiveness and cost of implementing a package of screening and treating syphilis and HIV in women of
reproductive age to improve maternal and perinatal health outcomes.
85 Antenatal care
Develop and evaluate a health systems package for effective task shifting for the management of obstetric emergencies,
including protocols, supervisory systems, and metrics
83 Health systems
NRPS: Normalized research priority score. This was performed by subtracting the minimum research priority score from the index question score, and dividing by
the NRPS range, i.e. (x −min)/(max −min).
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transparent the highly complex process of setting research
priorities. Overall, these methods are perceived as robust,
but there are some concerns related to the ability of these
methods to identify all relevant research ideas. In general,
most of the previous CHNRI exercises have relied on rela-
tively small reference groups (in general, < 100 partici-
pants). Small reference groups are more likely to be biased
by various elements of their composition and moredominant individuals within the group. In the present ex-
ercise, we tried to overcome these potential weaknesses by
increasing the number of participants and using distance-
based methods for collecting and scoring questions. Thus,
this became the largest exercise for prioritizing research
questions in maternal and perinatal health to date, involv-
ing a large number of experts and stakeholders, and with
a very large number of questions generated. However,
some limitations should be noted. Having a large group of
Table 4 Top five priority research questions addressing new health interventions (discovery questions) to improve
maternal and perinatal health
Research question NRPS Theme
Discover new formulations of uterotonics (e.g. low-cost, simple to use, non-invasive, heat-stable) to prevent and treat
PPH and improve maternal health outcomes.
72 Obstetric
haemorrhage
Discover and evaluate a standardised method of measuring blood loss to improve the detection and management of
PPH, to improve maternal health outcomes.
70 Obstetric
haemorrhage
Discover new technologies/screening tools for the detection of anaemia in pregnancy to improve maternal and
perinatal health outcomes.
66 Antenatal care
Discover and evaluate new methods/technologies to prevent and treat obstetric haemorrhage and improve maternal
health outcomes.
55 Obstetric
haemorrhage
Discover and evaluate new pharmaceutical treatments for eclampsia to improve maternal and perinatal outcomes. 48 HDP
HDP: hypertensive disorders of pregnancy.
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ensured broader representation and a very large pool of
research questions. However, managing a large number of
questions was technically challenging for all involved, par-
ticularly at list preparation (phase I) and scoring (phase II)
stages. Given the broad scope of this exercise (maternal
and perinatal health) and the long list of priority questions
to be scored, participant fatigue and time constraints were
of concern. For the set of 190 questions that was sent to
the reference group, each respondent had to attribute a
total of 950 scores (190 questions times five criteria),
which was a very time-intensive task. Anecdotal accounts
suggest that the time required to complete the task was
approximately four hours, however, some respondents re-
ported taking eight hours or more. This may explain the
substantial drop in response rate during phase III. Devel-
oping and testing simplified versions of the CHNRI
process could be explored as a way to strike a balance
between the necessary methodological rigor and practical
implementation. Another limitation of this method is
an apparent trend towards prioritizing implementation
research questions over discovery questions. This was
observed in this exercise and it has been a feature of other
CHNRI prioritization exercises; for example, in a similar
exercise for setting global mental health research prior-
ities, new interventions and technologies comprised seven
out of the ten lowest-scoring priorities, and none of the
top ten scoring priorities [17]. A possible explanation for
this could be that discovery questions tend to be more in-
novative and inherently riskier in terms of research invest-
ment while implementation research question seem to
respond concretely to immediate needs. Consensus-driven
processes are conservative by nature and as a result, re-
search questions that seem “safer” (e.g. implementation
research questions) could be more appealing to large con-
sultation groups. An additional explanation is that some
stakeholders are simply not aware of some of the new
technologies that are in earlier phases of development.
Thus, when asked to list research questions, they could
focus on the technologies that they know about. One mayquestion the validity of the CHNRI methodology to assess
research that is at the discovery stage as criteria such as
effectiveness, deliverability and equity are less relevant at
the discovery stage (though they may become more rele-
vant later, depending on the outcome of the primary re-
search). The method thus tends to systematically attribute
lower scores to discovery research. As future advances in
the field would depend on discovery research, in future
exercises, exploring ways of counter-balancing this trend
would be advisable; for example, conducting dedicated
modules with more relevant criteria (such as safety or
innovation) on discovery questions could avoid competi-
tion between different types of research questions.
The high ranking of priority research for abortion
and obstetric haemorrhage in this exercise reflects the
substantial contribution of these aspects to maternal
mortality and morbidity rates. Recurring sub-themes for
abortion research were mainly concerned with training
and/or awareness interventions, access to abortion, and
post-abortion care and contraception. Similarly, for ob-
stetric haemorrhage, training and/or awareness interven-
tions, and access to existing uterotonics were common
sub-themes. Given that both abortion and haemorrhage
are the most avoidable causes of maternal morbidity and
mortality, it is no surprise that priority questions focused
on the implementation/delivery of known effective inter-
ventions. Another recurring theme is research to address
cost-effectiveness knowledge gaps, which denotes the
importance of sustainability of new health technologies.
Health systems research had the second most research
questions in the top-20 list, illustrating the need for ef-
fective health systems to enable effective service delivery.
This emphasis on implementation research and health
system research suggest that the international commu-
nity is keen in overcoming barriers for using what is
already available rather than developing new technolo-
gies that may be not used due to the same reasons that
are currently preventing the use of existing health tech-
nology. As emphasis shift towards light technologies (i.e.
focus on work processes and system thinking) further
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generation are needed.
In this exercise, members of the reference group were
drawn from a diverse and widely representative group of
stakeholders, who contributed to, and scored, questions
according to well-defined criteria; therefore we consider
this exercise to reflect the priorities for global research
in maternal and perinatal health going forward. Unlike
most other priority setting exercises using the CHNRI
approach, we did not weight the criteria used for setting
priorities, but have published the complete list of re-
search questions with individual criteria scores. This
should enable stakeholders to generate customized re-
search priorities according to their own weightings (e.g.
a donor agency may wish to promote research questions
that contribute more to health equity, or a governmental
foundation may wish to tackle research questions that
will have the largest impact on the disease burden), and
risk management preferences.
Conclusions
Key research priorities in maternal and perinatal health
were identified. The resulting ranked list of research
questions provides a valuable resource for health re-
search investors, researchers and other stakeholders. We
are hopeful that this exercise will inform the post-2015
Development Agenda and assist donors, research-policy
decision makers and researchers to invest in research
that will ultimately make the most significant difference
in the lives of mothers and babies.
Appendix 1
BiomedExperts search strategy
BiomedExperts is a free online service for the life sciences
community to connect, network, communicate and col-
laborate. BiomedExperts contains the research profiles of
more than 1.8 million life science researchers, represent-
ing over 26 million connections from over 2,700 institu-
tions in more than 160 countries. These profiles were
generated from author and co-author information from
18 million publications published in over 20,000 journals.
Search strategy
Keywords/areas of research searched:
 Caesarean section
 Eclampsia
 Fistula
 Labour complications
 Maternal mortality
 Postpartum haemorrhage
 Preeclampsia
 Pregnancy induced hypertension
 Preterm births Sepsis
 Still births
Identification of researchers
For each of the above areas, we chose the first 20 authors
at “Global” level that published the highest number of arti-
cles related to that area, the first 10 authors at coauthors
level 1 (“your coauthors”) and the first 10 authors at coau-
thors level 2 (“coauthors of your coauthors”). The identifi-
cation of researchers was stratified to ensure participation
of researchers from both developed and developing
countries.
Additional file
Additional file 1: Final list of research questions.
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